SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-20-094194
Filing Date
2020-08-12
Accepted
2020-08-12 21:17:35
Documents
1
Period of Report
2020-08-10

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 4032
  Complete submission text file 0001104659-20-094194.txt   5517
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Issuer) CIK: 0001509745 (see all company filings)

IRS No.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O TRANSCEPT PHARMACEUTICAL, INC. 1003 W. CUTTING BLVD, STE 110 PT. RICHMOND CA 94804
Business Address
Dietz Thomas John (Reporting) CIK: 0001574218 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37990 | Film No.: 201096903